Metvixia is a prescription medication that is used in the treatment of actinic keratosis, a common skin condition caused by sun exposure. This medication contains the active ingredient methyl aminolevulinate, which is a photosensitizing agent that works by making the affected skin cells more sensitive to light.

Metvixia is typically applied to the affected area of the skin and left on for a period of time before being activated by a special light source. This process, known as photodynamic therapy, helps to target and destroy the abnormal skin cells while minimizing damage to surrounding healthy tissue.

It is important to follow your healthcare provider’s instructions carefully when using Metvixia, as improper use can lead to adverse effects such as redness, swelling, and blistering of the skin. It is also important to avoid exposure to sunlight or bright indoor light for a period of time after treatment, as this can increase the risk of skin reactions.

Before using Metvixia, be sure to inform your healthcare provider of any allergies or medical conditions you may have, as well as any medications you are currently taking. Your healthcare provider will be able to determine if Metvixia is the right treatment option for you based on your individual needs and medical history.

Overall, Metvixia can be an effective and safe treatment option for actinic keratosis when used as directed by a healthcare provider. If you have any questions or concerns about this medication, do not hesitate to speak with your healthcare provider for more information.